Maternal hypertensive disorders, antihypertensive medication use, and the risk of birth defects: A case-control study

BJOG: An International Journal of Obstetrics and Gynaecology

Volumn 122, Issue 7, 2015, Pages 1002-1009

  Van Gelder, M M H J ^a   Van Bennekom, C M ^b   Louik, C ^b   Werler, M M ^b   Roeleveld, N ^a   Mitchell, A A ^b  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b BOSTON UNIVERSITY   (United States)

Author keywords

Antihypertensive agents; cardiovascular abnormalities; congenital malformations; hypertensive disorders in pregnancy; hypospadias; oesophageal atresia

Indexed keywords

ADRENERGIC RECEPTOR BLOCKING AGENT; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; VASODILATOR AGENT;

ADULT; AORTA ARCH ANOMALY; ARTICLE; CARDIOVASCULAR RISK; CASE CONTROL STUDY; CLEFT LIP; CLEFT PALATE; CONGENITAL MALFORMATION; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; ESOPHAGUS ATRESIA; FEMALE; GASTROSCHISIS; HEART ATRIUM SEPTUM DEFECT; HEART VENTRICLE SEPTUM DEFECT; HUMAN; HYPOSPADIAS; INFANT; MAJOR CLINICAL STUDY; MATERNAL HYPERTENSION; PATHOGENESIS; PREECLAMPSIA; PRENATAL DRUG EXPOSURE; PRIORITY JOURNAL; ABNORMALITIES, DRUG-INDUCED; CHEMICALLY INDUCED; HYPERTENSION, PREGNANCY-INDUCED; PRE-ECLAMPSIA; PREGNANCY; PREGNANCY COMPLICATIONS, CARDIOVASCULAR; PRENATAL EXPOSURE; RISK FACTOR; TREATMENT OUTCOME; YOUNG ADULT;

ABNORMALITIES, DRUG-INDUCED; ADULT; ANTIHYPERTENSIVE AGENTS; CASE-CONTROL STUDIES; FEMALE; HUMANS; HYPERTENSION, PREGNANCY-INDUCED; PRE-ECLAMPSIA; PREGNANCY; PREGNANCY COMPLICATIONS, CARDIOVASCULAR; PRENATAL EXPOSURE DELAYED EFFECTS; RISK FACTORS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84930035524     PISSN: 14700328     EISSN: 14710528     Source Type: Journal    
DOI: 10.1111/1471-0528.13138     Document Type: Article

References (34)

1. Report of the National High Blood Pressure Education Program Working Group on high blood pressure in pregnancy. Am J Obstet Gynecol 2000; 183: S1-22.
2. Hutcheon JA, Lisonkova S, Joseph KS,. Epidemiology of pre-eclampsia and the other hypertensive disorders of pregnancy. Best Pract Res Clin Obstet Gynaecol 2011; 25: 391-403.
3. Khan KS, Wojdyla D, Say L, Gülmezoglu AM, Van Look PFA,. WHO analysis of causes of maternal death: a systematic review. Lancet 2006; 367: 1066-74.
4. Magee LA, Abalos E, von Dadelszen P, Sibai B, Easterling T, Walkinshaw S,. How to manage hypertension in pregnancy effectively. Br J Clin Pharmacol 2011; 72: 394-401.
5. Van Gelder MMHJ, van Rooij IALM, Miller RK, Zielhuis GA, de Jong-van den Berg LTW, Roeleveld N,. Teratogenic mechanisms of medical drugs. Hum Reprod Update 2010; 16: 378-94.
6. Li DK, Yang C, Andrade S, Tavares V, Ferber JR,. Maternal exposure to angiotensin converting enzyme inhibitors in the first trimester and risk of malformations in offspring: a retrospective cohort study. BMJ 2011; 343: d5931.
7. Cooper WO, Hernandez-Diaz S, Arbogast PG, Dudley JA, Dyer S, Gideon PS, et al., Major congenital malformations after first-trimester exposure to ACE inhibitors. N Engl J Med 2006; 354: 2443-51.
8. Caton AR, Bell EM, Druschel CM, Werler MM, Lin AE, Browne ML, et al., Antihypertensive medication use during pregnancy and the risk of cardiovascular malformations. Hypertension 2009; 54: 63-70.
9. Lennestål R, Otterblad Olausson P, Källén B,. Maternal use of antihypertensive drugs in early pregnancy and delivery outcome, notably the presence of congenital heart defects in the infants. Eur J Clin Pharmacol 2009; 65: 615-25.
10. Caton AR, Bell EM, Druschel CM, Werler MM, Mitchell AA, Browne ML, et al., Maternal hypertension, antihypertensive medication use, and the risk of severe hypospadias. Birth Defects Res A Clin Mol Teratol 2008; 82: 34-40.
11. Puhõ EH, Szunyogh M, Métneki J, Czeizel AE,. Drug treatment during pregnancy and isolated orofacial clefts in hungary. Cleft Palate Craniofac J 2007; 44: 194-202.
12. Werler MM, Mitchell AA, Moore CA, Honein MA,. Is there epidemiologic evidence to support vascular disruption as a pathogenesis of gastroschisis? Am J Med Genet A 2009; 149A: 1399-406.
13. Queiβer-Luft A, Eggers I, Stolz G, Kieninger-Baum D, Schlaefer K,. Serial examination of 20,248 newborn fetuses and infants: correlations between drug exposure and major malformations. Am J Med Genet 1996; 63: 268-76.
14. Weber-Schoendorfer C, Hannemann D, Meister R, Eléfant E, Cuppers-Maarschalkerweerd B, Arnon J, et al., The safety of calcium channel blockers during pregnancy: a prospective, multicenter, observational study. Reprod Toxicol 2008; 26: 24-30.
15. Nakhai-Pour HR, Rey E, Bérard A,. Antihypertensive medication use during pregnancy and the risk of major congenital malformations or small-for-gestational-age newborns. Birth Defects Res B Dev Reprod Toxicol 2010; 89: 147-54.
16. Diav-Citrin O, Shechtman S, Halberstadt Y, Finkel-Pekarsky V, Wajnberg R, Arnon J, et al., Pregnancy outcome after in utero exposure to angiotensin converting enzyme inhibitors or angiotensin receptor blockers. Reprod Toxicol 2011; 31: 540-5.
17. Van Zutphen AR, Werler MM, Browne MM, Romitti PA, Bell EM, McNutt LA, et al., Maternal hypertension, medication use, and hypospadias in the National Birth Defects Prevention Study. Obstet Gynecol 2014; 123: 309-17.
18. Bánhidy F, Ács N, Puhõ EH, Czeizel AE,. Chronic hypertension with related drug treatment of pregnant women and congenital abnormalities in their offspring: a population-based study. Hypertens Res 2011; 34: 257-63.
19. Bánhidy F, Szilasi M, Czeizel AE,. Association of pre-eclampsia with or without superimposed chronic hypertension in pregnant women with the risk of congenital abnormalities in their offspring: a population-based case-control study. Eur J Obstet Gynecol Reprod Biol 2012; 163: 17-21.
20. Brouwers MM, van der Zanden LFM, de Gier RPE, Barten EJ, Zielhuis GA, Feitz WFJ, et al., Hypospadias: risk factor patterns and different phenotypes. BJU Int 2010; 105: 254-62.
21. Werler MM, Bosco JLF, Shapira SK,. Maternal vasoactive exposures, amniotic bands, and terminal transverse limb deficiencies. Birth Defects Res A Clin Mol Teratol 2009; 85: 52-7.
22. Glickman ME, Rao SR, Schultz MR,. False discovery rate control is a recommended alternative to Bonferroni-type adjustments in health studies. J Clin Epidemiol 2014; 67: 850-7.
23. Akre O, Lipworth L, Cnattingius S, Sparén P, Ekbom A,. Risk factor patterns for cryptorchidism and hypospadias. Epidemiology 1999; 10: 364-9.
24. Aschim EL, Haugen TB, Tretli S, Daltveit AK, Grotmol T,. Risk factors for hypospadias in Norwegian boys-association with testicular dysgenesis syndrome? Int J Androl 2004; 27: 213-21.
25. Sørensen HT, Pedersen L, Nørgaard M, Wogelius P, Rothman KJ,. Maternal asthma, preeclampsia and risk of hypospadias. Epidemiology 2005; 16: 806-7.
26. Payne NR, Pfleghaar KM, Blauer C, Finkelstein M, Olsen S,. The inverse association between gastroschisis and gestational hypertension. J Neonatal Perinatal Med 2011; 4: 211-20.
27. Ros HS, Cnattingius S, Lipworth L,. Comparison of risk factors for preeclampsia and gestational hypertension in a population-based cohort study. Am J Epidemiol 1998; 147: 1062-70.
28. Cotter AM, Molloy AM, Scott JM, Daly SF,. Elevated plasma homocysteine in early pregnancy: a risk factor for the development of severe preeclampsia. Am J Obstet Gynecol 2001; 185: 781-5.
29. Dodds L, Fell DB, Dooley KC, Armson BA, Allen AC, Nassar BA, et al., Effect of homocysteine concentration in early pregnancy on gestational hypertensive disorders and other pregnancy outcomes. Clin Chem 2008; 54: 326-34.
30. Stothard KJ, Tennant PW, Bell R, Rankin J,. Maternal overweight and obesity and the risk of congenital anomalies: a systematic review and meta-analysis. JAMA 2009; 301: 636-50.
31. Correa A, Gilboa SM, Besser LM, Botto LD, Moore CA, Hobbs CA, et al., Diabetes mellitus and birth defects. Am J Obstet Gynecol 2008; 199: 237.e1-9.
32. Verkleij-Hagoort A, Bliek J, Sayed-Tabatabaei F, Ursem N, Steegers E, Steegers-Theunissen R,. Hyperhomocysteinemia and MTHFR polymorphisms in association with orofacial clefts and congenital heart defects: a meta-analysis. Am J Med Genet A 2007; 143A: 952-60.
33. Myatt L, Webster RP,. Vascular biology of preeclampsia. J Thromb Haemost 2009; 7: 375-84.
34. Fujimoto T, Suwa T, Kabe K, Adachi T, Nakabayashi M, Amamiya T,. Placental insufficiency in early gestation is associated with hypospadias. J Pediatr Surg 2008; 43: 358-61.